Attenuation of neurovirulence, biodistribution, and shedding of a poliovirus:rhinovirus chimera after intrathalamic inoculation in Macaca fascicularis.
about
Therapeutic and prevention strategies against human enterovirus 71 infectionRNA virus reverse genetics and vaccine design.Oncolytic viruses: From bench to bedside with a focus on safety.Oncolytic polio virotherapy of cancerInduction of viral, 7-methyl-guanosine cap-independent translation and oncolysis by mitogen-activated protein kinase-interacting kinase-mediated effects on the serine/arginine-rich protein kinase.Mitogen-activated protein kinase-interacting kinase regulates mTOR/AKT signaling and controls the serine/arginine-rich protein kinase-responsive type 1 internal ribosome entry site-mediated translation and viral oncolysis.EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMAEnhancing the Tumor Selectivity of a Picornavirus Virotherapy Promotes Tumor Regression and the Accumulation of Infiltrating CD8+ T Cells.Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirusOncolytic immunotherapy through tumor-specific translation and cytotoxicity of poliovirus.Viral vectors for therapy of neurologic diseases.Developing anti-neoplastic biotherapeutics against eIF4F.The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.Recombinant Poliovirus for Cancer Immunotherapy.Current state and future prospects of immunotherapy for glioma.Recurrent Glioblastoma Treated with Recombinant Poliovirus.Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells
P2860
Q28080796-234C9250-3E83-49CD-AF14-5E636610A84FQ33963398-B432DC20-0071-4A13-A3AE-DD59E01BAAFBQ34044071-5D7269A5-C860-4421-83B9-43E81FB0DA5CQ34425385-68D3DF8F-A6FF-4D71-9369-FAD7B47A9909Q34594574-5C235A5A-BE97-4E5B-906C-E3FD69CFE2EAQ34594617-C92A99CC-9B32-4AF5-95CD-FAE7DA3DE84CQ36549443-C3AA3A8E-9D4F-45FD-A67E-33742BEC23EFQ36665114-CCFBEC5F-1E05-4AB2-80C1-17404C5736B8Q38530234-70869C26-70DA-4EF9-8DD5-12BAD6602455Q38536420-87D2F7C3-1EC5-4CE9-974A-BE321B7885F2Q38746238-D7EF9001-8B4D-4C57-AAC3-3F8705B310F8Q39048156-9AC73BC0-2EED-441B-BE18-760153E756F2Q39294814-812FCF60-6160-4254-911A-961207C54DFFQ48319918-3A7F8BD7-34CE-4AC6-84C0-B6F1B2A7DB5EQ48508304-19B904B5-8EE3-4907-914F-F458A685330FQ50109459-39396BF0-E55C-4E94-8F26-83D21E04E6C4Q55456747-8A8DBF24-3140-4DD8-B1AF-63FCF23F296BQ57753028-7BDDB556-2F56-4AEB-B0EC-643C7E3AC323
P2860
Attenuation of neurovirulence, biodistribution, and shedding of a poliovirus:rhinovirus chimera after intrathalamic inoculation in Macaca fascicularis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Attenuation of neurovirulence, ...... lation in Macaca fascicularis.
@ast
Attenuation of neurovirulence, ...... lation in Macaca fascicularis.
@en
type
label
Attenuation of neurovirulence, ...... lation in Macaca fascicularis.
@ast
Attenuation of neurovirulence, ...... lation in Macaca fascicularis.
@en
prefLabel
Attenuation of neurovirulence, ...... lation in Macaca fascicularis.
@ast
Attenuation of neurovirulence, ...... lation in Macaca fascicularis.
@en
P2093
P2860
P356
P1433
P1476
Attenuation of neurovirulence, ...... lation in Macaca fascicularis.
@en
P2093
Christian Goetz
Elena Y Dobrikova
Eric M Vela
James E Estep
James O Peggins
Karen Muszynski
Karyol Poole
Matthias Gromeier
Robert W Walters
Sarah K Lawson
P2860
P304
P356
10.1128/JVI.06427-11
P407
P577
2011-12-14T00:00:00Z